These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37958877)

  • 21. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from
    Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S
    J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment.
    Velagacherla V; Suresh A; Mehta CH; Nayak UY; Nayak Y
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
    Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO
    J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
    Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
    J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.
    Shode FO; Idowu ASK; Uhomoibhi OJ; Sabiu S
    J Biomol Struct Dyn; 2022 Sep; 40(14):6587-6602. PubMed ID: 33590806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M
    Kakhar Umar A; Zothantluanga JH; Luckanagul JA; Limpikirati P; Sriwidodo S
    PeerJ; 2023; 11():e14915. PubMed ID: 36935912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein.
    Salamat A; Kosar N; Mohyuddin A; Imran M; Zahid MN; Mahmood T
    Molecules; 2024 Mar; 29(5):. PubMed ID: 38474656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential phytochemicals from
    Khan J; Sakib SA; Mahmud S; Khan Z; Islam MN; Sakib MA; Emran TB; Simal-Gandara J
    J Biomol Struct Dyn; 2022; 40(21):10741-10752. PubMed ID: 34278965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chetomin, a SARS-CoV-2 3C-like Protease (3CL
    Ibrahim MAA; Abdelrahman AHM; Mohamed DEM; Abdeljawaad KAA; Naeem MA; Gabr GA; Shawky AM; Soliman MES; Sidhom PA; Paré PW; Hegazy MF
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay.
    Stewart J; Shawon J; Ali MA; Williams B; Shahinuzzaman ADA; Rupa SA; Al-Adhami T; Jia R; Bourque C; Faddis R; Stone K; Sufian MA; Islam R; McShan AC; Rahman KM; Halim MA
    J Pept Sci; 2024 Apr; 30(4):e3553. PubMed ID: 38031661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors.
    Tripathi N; Goel B; Bhardwaj N; Sahu B; Kumar H; Jain SK
    J Biomol Struct Dyn; 2022 May; 40(8):3655-3667. PubMed ID: 33213294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
    Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
    Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations.
    Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B
    SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease.
    Elkaeed EB; Youssef FS; Eissa IH; Elkady H; Alsfouk AA; Ashour ML; El Hassab MA; Abou-Seri SM; Metwaly AM
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
    BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.